L
Laura Pardo
Researcher at Autonomous University of Barcelona
Publications - 7
Citations - 133
Laura Pardo is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Head and neck squamous-cell carcinoma & Chemoradiotherapy. The author has an hindex of 3, co-authored 7 publications receiving 77 citations.
Papers
More filters
Journal ArticleDOI
Pretreatment count of peripheral neutrophils, monocytes, and lymphocytes as independent prognostic factor in patients with head and neck cancer.
Cristina Valero,Laura Pardo,Montserrat López,Jacinto García,Mercedes Camacho,Miquel Quer,Xavier León +6 more
TL;DR: The purpose of this study was to analyze the prognostic value of pretreatment count of peripheral neutrophils, lymphocytes, monocytes, and neutrophil‐to‐lymphocyte ratio (NLR) in patients with head and neck squamous cell carcinoma (HNSCC).
Journal ArticleDOI
Prognostic capacity of Systemic Inflammation Response Index (SIRI) in patients with head and neck squamous cell carcinoma
Cristina Valero,Laura Pardo,Aina Sansa,Jacinto García Lorenzo,Montserrat López,Miquel Quer,Xavier León +6 more
TL;DR: The aim of this study is to analyze Systemic Inflammation Response Index's prognostic capacity in head and neck squamous cell carcinomas (HNSCC).
Journal ArticleDOI
The prognostic value of pretreatment platelet count in patients with head and neck squamous cell carcinoma
Laura Pardo,Cristina Valero,Montserrat López,Jacinto García,Mercedes Camacho,Miquel Quer,Xavier León +6 more
TL;DR: Platelet count was significantly associated with survival in univariate analysis, however, in a multivariate analysis it lost its prognostic capacity, limiting its utility as a prognostic marker in patients with HNSCC.
Journal ArticleDOI
Prognostic significance of albumin levels prior to treatment in patients with head and neck squamous cell carcinoma.
Xavier León,Laura Pardo,Aina Sansa,Rocio Puig,Cristina Serrano,Montserrat López,Miquel Quer,Cristina Valero +7 more
TL;DR: Pre-treatment plasmatic albumin is an independent prognostic factor for patients with advanced stage HNSCC (III-IV), 37.5 g/L being the cut-off point with the highest prognostic capacity.
Journal ArticleDOI
The aspartate aminotransaminase/alanine aminotransaminase (De Ritis) ratio predicts sensitivity to radiotherapy in head and neck carcinoma patients.
Aina Sansa,María del Prado Venegas,Cristina Valero,Laura Pardo,Francesc-Xavier Avilés-Jurado,Ximena Terra,Miquel Quer,Xavier León +7 more
TL;DR: In this paper, the authors evaluated the relationship between the aspartate aminotransaminase (AST) and alanine AMINOTE (ALT) ratio and local disease control in patients with head and neck squamous cell carcinomas (HNSCC) treated with radiotherapy/chemoradiotherapy.